VCA-894A
VP-VCA-894A-2101
Phase 2 small_molecule active
Quick answer
VCA-894A for Charcot Marie Tooth Disease (CMT) is a Phase 2 program (small_molecule) at Vanda Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Charcot Marie Tooth Disease (CMT)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active